| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 60,426 | 58,727 | 48,020 | 49,795 | | Cost of Revenue | 49,445 | 46,129 | 38,115 | 51,273 | | | Gross Profit | 10,981 | 12,598 | 9,905 | (1,478) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,034 | 8,559 | 7,535 | 16,838 | | Non Recurring |
-
|
-
|
-
| 2,442 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,947 | 4,039 | 2,370 | (20,758) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 451 | 148 | 754 | (1,035) | | Earnings Before Interest And Taxes | 3,398 | 4,187 | 3,124 | (21,793) | | Interest Expense | 291 | 318 | 267 | 471 | | Income Before Tax | 3,107 | 3,869 | 2,857 | (22,264) | | Income Tax Expense | 1,336 | 1,432 | 1,057 | (7,276) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,771 | 2,437 | 1,800 | (14,988) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| 695 | | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,771 | 2,437 | 1,800 | (14,293) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,771 | $2,437 | $1,800 | ($14,293) |
|
0.50% Nasdaq 
Income Statement
